Skip to main content
See every side of every news story
Published • loading... • Updated

Alkermes to Present at Upcoming Investor Conferences

The company plans a Jefferies fireside chat and a psychedelics panel, with webcasts and replays available for 90 days after each event.

  • On Wednesday, November 4, 2026, multiple biopharmaceutical companies including Incyte and Definium Therapeutics announced participation in upcoming November investor conferences.
  • Management teams use these conferences to provide updates on clinical pipelines and engage directly with investors regarding long-term corporate strategies and financial goals.
  • Definium Therapeutics will present at the Stifel 2026 Healthcare Conference and the Jefferies Global Healthcare Conference in London, with a fireside chat on November 17 and psychedelics panel on November 19.
  • Incyte scheduled presentations for the Wolfe Research Healthcare Conference on November 10 and the UBS Global Biopharma Conference on November 17, while Alkermes plc confirmed management participation in two upcoming events.
  • Beyond healthcare, Sterling Infrastructure, Inc. will attend the Baird Global Industrial Conference in Chicago on November 11 to present its industrial and infrastructure project portfolio.
Insights by Ground AI

16 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 50% of the sources lean Left, 50% of the sources are Center
50% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

stocktitan.net broke the news on Tuesday, November 3, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal